Circulating Neutrophil Profiles Undergo a Dynamic Shift during Metabolic Dysfunction-Associated Steatohepatitis (MASH) Progression

被引:1
|
作者
Maretti-Mira, Ana C. [1 ]
Salomon, Matthew P. [1 ]
Chopra, Shefali [2 ]
Yuan, Liyun [1 ]
Golden-Mason, Lucy [1 ]
机构
[1] Univ Southern Calif, USC Res Ctr Liver Dis, Dept Med, Div Gastrointestinal & Liver Dis,Keck Sch Med, Los Angeles, CA 90033 USA
[2] Univ Southern Calif, Keck Sch Med, Dept Pathol, Los Angeles, CA 90033 USA
基金
美国国家卫生研究院;
关键词
metabolic dysfunction-associated steatotic liver disease (MASLD); innate immunity; transcriptomics; inflammation; metabolic dysfunction-associated steatohepatitis (MASH); neutrophils; FATTY LIVER-DISEASE; INNATE; CELLS; INFLAMMATION; MACROPHAGES; FIBROSIS; PROMOTES; BURDEN; SERVER; NAFLD;
D O I
10.3390/biomedicines12051105
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Neutrophils play a crucial role in host defense against infection. Aberrant neutrophil activation may induce tissue damage via sterile inflammation. Neutrophil accumulation has been identified as a feature of the inflammatory response observed in metabolic dysfunction-associated steatohepatitis (MASH) and has been associated with liver fibrosis and cirrhosis. Here, we performed the transcriptomic analysis of circulating neutrophils from mild and advanced MASH patients to identify the potential mechanism behind neutrophil contribution to MASH progression. Our findings demonstrated that circulating neutrophils from mild and advanced MASH display an increased activated transcriptional program, with the expression of pro-inflammatory factors and an amplified lifespan compared to cells from non-diseased controls. Our results also suggest that MASH progression is associated with a dynamic shift in the profile of circulating neutrophils. In the early stages of MASH, mature neutrophils predominate in the bloodstream. As hepatic inflammation and fibrosis progress, the premature release of immature neutrophils into the circulation occurs. These immature neutrophils exhibit a pro-inflammatory profile that may exacerbate inflammation and promote fibrosis in MASH.
引用
收藏
页数:14
相关论文
共 50 条
  • [1] Therapeutic landscape of metabolic dysfunction-associated steatohepatitis (MASH)
    Do, Albert
    Zahrawi, Frhaan
    Mehal, Wajahat Z.
    NATURE REVIEWS DRUG DISCOVERY, 2025, 24 (03) : 171 - 189
  • [2] Therapeutic landscape of metabolic dysfunction-associated steatohepatitis (MASH)
    Do, Albert
    Zahrawi, Frhaan
    Mehal, Wajahat Z.
    NATURE REVIEWS DRUG DISCOVERY, 2024,
  • [3] Therapeutic landscape of metabolic dysfunction-associated steatohepatitis (MASH)
    Albert Do
    Frhaan Zahrawi
    Wajahat Z. Mehal
    Nature Reviews Drug Discovery, 2025, 24 (3) : 171 - 189
  • [4] Silent MASH: A Case of Metabolic Dysfunction-Associated Steatohepatitis (MASH) with Normal Aminotransferases
    Li, Elizabeth
    Vallabhaneni, Manasa
    Lin, Joanne
    Hogan, Carolyn
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2024, 119 (10S): : S2778 - S2778
  • [5] IMPACT OF FIBROSIS SEVERITY ON CLINICAL AND METAGENOMIC PROFILES IN MASH (METABOLIC DYSFUNCTION-ASSOCIATED STEATOHEPATITIS) PATIENTS
    Joung, Hyunchae
    Joo, Jaeryang
    Kim, KyungHwan
    Shin, Chang Hun
    Lee, Hye Won
    HEPATOLOGY, 2024, 80 : S788 - S789
  • [6] Metabolic dysfunction-associated steatohepatitis (MASLD) and metabolic dysfunction-associated steatohepatitis (MASH) require urgent attention by primary care physicians and endocrinologists
    Mauricio, Didac
    Escalada, Javier
    Perez, Antonio
    Romero-Gomez, Manuel
    Cusi, Kenneth
    Younoussi, Zobair M.
    Lazarus, Jeffrey V.
    ENDOCRINOLOGIA DIABETES Y NUTRICION, 2024, 71 (04): : 149 - 151
  • [7] Found in translation-Fibrosis in metabolic dysfunction-associated steatohepatitis (MASH)
    Wang, Shuang
    Friedman, Scott L.
    SCIENCE TRANSLATIONAL MEDICINE, 2023, 15 (716)
  • [8] Evaluating the Impact of Cenicriviroc in Metabolic Dysfunction-Associated Steatohepatitis (MASH): A Systematic Review
    Singh, Avneet
    Garcia, Alexander
    Hasan, Fariha
    Laique, Fatima
    Mohiuddin, Mubashir
    Haris, Muhammad
    Abidi, Zehara
    Jover, Queenzy
    Awadallah, Mina
    Wakil, Ali
    Nguyen, Tommy
    Roy, Satyajeet
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2024, 119 (10S): : S1249 - S1250
  • [9] Fasting Insulin as an Independent Predictor of Metabolic Dysfunction-Associated Steatohepatitis (MASH) Severity
    Harrison, Stephen A.
    Dubourg, Julie
    Jeannin, Sophie
    Colca, Jerry R.
    Ratziu, Vlad
    DIABETES, 2024, 73
  • [10] RECOMMENDATIONS FOR METABOLIC DYSFUNCTION-ASSOCIATED STEATOHEPATITIS ( MASH) DISEASE MANAGEMENT: A MODIFIED DELPHI PANEL
    Watzker, Anna
    Delegge, Mark
    Fernandes, Gail
    Melaragno, Matthew
    Williams, Rhys
    Godinho, Fatima
    Drymaliti, Kyriaki
    Engel, Samuel
    HEPATOLOGY, 2024, 80